FDA likely will need to issue guidance to clarify exactly what materials are covered by the ban on plastic microbead use in selected personal-care products – i.e., a definition of “plastic” – and what the consequences of a violation could be. The issue could be of particular relevance to companies exploring gray-area replacement materials such as biodegradable PHA.
Violators of the US ban on plastic microbead-containing cosmetics could face warning letters and other enforcement actions from FDA once phase-out deadlines kick in, but the biggest threat could be of a PR, rather than compliance, nature.
Those considering borderline replacement materials should weigh potential benefits and risks accordingly.
Create an account to read this article
Already a subscriber?
While FDA fully supports the recent roadmap to reduce and eliminate animal testing, animal tests are still necessary for assessing systemic effects, says Jacqueline Corrigan-Curay, acting director for CDER, during a House Energy and Commerce Health Subcommittee hearing.
The European Commission’s Simplification Omnibus published July 8 is ‘step in right direction’ for streamlining processes and providing more legal certainty and predictability for regulations addressing cosmetics, says Cosmetics Europe.
White House announces president extends deadline he set in April for other countries to make new tariff deals from July 9 to Aug. 1, when the administration will start sending letters warning other countries that higher tariffs could take effect.
ECHA has added two silicone ingredients used in cosmetics and personal care products to the REACH Candidate List as they are persistent and have bioaccumulative properties, requiring companies to notify customers and update safety data sheets if concentrations exceed 0.1%.
Stakeholders are still waiting for the US FDA to issue its widely anticipated proposed rule to prohibit formaldehyde and formaldehyde releasers from hair smoothing or straightening products.
White House announces president extends deadline he set in April for other countries to make new tariff deals from July 9 to Aug. 1, when the administration will start sending letters warning other countries that higher tariffs could take effect.
An FDA “expert roundtable” on talc produced a new talking point on a potential drug safety risk, but the basis of that claim is difficult to determine.
